These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 16094559)

  • 1. Minimum inhibitory concentrations of tulathromycin against respiratory bacterial pathogens isolated from clinical cases in European cattle and swine and variability arising from changes in in vitro methodology.
    Godinho KS; Keane SG; Nanjiani IA; Benchaoui HA; Sunderland SJ; Jones MA; Weatherley AJ; Gootz TD; Rowan TG
    Vet Ther; 2005; 6(2):113-21. PubMed ID: 16094559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility testing of tulathromycin: interpretative breakpoints and susceptibility of field isolates.
    Godinho KS
    Vet Microbiol; 2008 Jun; 129(3-4):426-32. PubMed ID: 18187275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of tulathromycin in the treatment and prevention of natural outbreaks of bovine respiratory disease in European cattle.
    Godinho KS; Wolf RM; Sherington J; Rowan TG; Sunderland SJ; Evans NA
    Vet Ther; 2005; 6(2):122-35. PubMed ID: 16094560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of tulathromycin injectable solution for the treatment of naturally occurring Swine respiratory disease.
    Nutsch RG; Hart FJ; Rooney KA; Weigel DJ; Kilgore WR; Skogerboe TL
    Vet Ther; 2005; 6(2):214-24. PubMed ID: 16094568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the therapeutic activity of tulathromycin against swine respiratory disease on farms in Europe.
    Nanjiani IA; McKelvie J; Benchaoui HA; Godinho KS; Sherington J; Sunderland SJ; Weatherley AJ; Rowan TG
    Vet Ther; 2005; 6(2):203-13. PubMed ID: 16094567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutant prevention and minimum inhibitory concentration drug values for enrofloxacin, ceftiofur, florfenicol, tilmicosin and tulathromycin tested against swine pathogens Actinobacillus pleuropneumoniae, Pasteurella multocida and Streptococcus suis.
    Blondeau JM; Fitch SD
    PLoS One; 2019; 14(1):e0210154. PubMed ID: 30629633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activities of tulathromycin and ceftiofur combined with other antimicrobial agents using bovine Pasteurella multocida and Mannheimia haemolytica isolates.
    Sweeney MT; Brumbaugh GW; Watts JL
    Vet Ther; 2008; 9(3):212-22. PubMed ID: 19003782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial susceptibility monitoring of respiratory tract pathogens isolated from diseased cattle and pigs across Europe: the VetPath study.
    de Jong A; Thomas V; Simjee S; Moyaert H; El Garch F; Maher K; Morrissey I; Butty P; Klein U; Marion H; Rigaut D; Vallé M
    Vet Microbiol; 2014 Aug; 172(1-2):202-15. PubMed ID: 24837878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial susceptibility patterns and sensitivity to tulathromycin in goat respiratory bacterial isolates.
    Clothier KA; Kinyon JM; Griffith RW
    Vet Microbiol; 2012 Apr; 156(1-2):178-82. PubMed ID: 22078276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the antimicrobial activity of florfenicol against bacteria isolated from bovine and porcine respiratory disease.
    Shin SJ; Kang SG; Nabin R; Kang ML; Yoo HS
    Vet Microbiol; 2005 Mar; 106(1-2):73-7. PubMed ID: 15737475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limitations of bacterial culture, viral PCR, and tulathromycin susceptibility from upper respiratory tract samples in predicting clinical outcome of tulathromycin control or treatment of bovine respiratory disease in high-risk feeder heifers.
    Sarchet JJ; Pollreisz JP; Bechtol DT; Blanding MR; Saltman RL; Taube PC
    PLoS One; 2022; 17(2):e0247213. PubMed ID: 35143504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the RapID NH system for identification of Haemophilus somnus, Pasteurella multocida, Pasteurella haemolytica, and Actinobacillus pleuropneumoniae isolated from cattle and pigs with respiratory disease.
    Salmon SA; Watts JL; Yancey RJ
    J Clin Microbiol; 1993 May; 31(5):1362-3. PubMed ID: 8501242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A large potentiation effect of serum on the in vitro potency of tulathromycin against Mannheimia haemolytica and Pasteurella multocida.
    Lees P; Illambas J; Potter TJ; Pelligand L; Rycroft A; Toutain PL
    J Vet Pharmacol Ther; 2017 Oct; 40(5):419-428. PubMed ID: 27891615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seven years survey of susceptibility to marbofloxacin of bovine pathogenic strains from eight European countries.
    Meunier D; Acar JF; Martel JL; Kroemer S; Vallé M
    Int J Antimicrob Agents; 2004 Sep; 24(3):268-78. PubMed ID: 15325431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tulathromycin: an overview of a new triamilide antibiotic for livestock respiratory disease.
    Evans NA
    Vet Ther; 2005; 6(2):83-95. PubMed ID: 16094557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of in vitro minimum inhibitory concentrations of tilmicosin against Mannheimia haemolytica and Pasteurella multocida and in vivo tilmicosin treatment outcome among calves with signs of bovine respiratory disease.
    McClary DG; Loneragan GH; Shryock TR; Carter BL; Guthrie CA; Corbin MJ; Mechor GD
    J Am Vet Med Assoc; 2011 Jul; 239(1):129-35. PubMed ID: 21718206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and antimicrobial susceptibility of Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni isolated from the lower respiratory tract of healthy feedlot cattle and those diagnosed with bovine respiratory disease.
    Timsit E; Hallewell J; Booker C; Tison N; Amat S; Alexander TW
    Vet Microbiol; 2017 Sep; 208():118-125. PubMed ID: 28888626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial resistance genes in Actinobacillus pleuropneumoniae, Haemophilus parasuis and Pasteurella multocida isolated from Australian pigs.
    Dayao D; Gibson JS; Blackall PJ; Turni C
    Aust Vet J; 2016 Jul; 94(7):227-31. PubMed ID: 27349882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial susceptibility of Actinobacillus pleuropneumoniae, Pasteurella multocida and Salmonella choleraesuis isolates from pigs.
    Raemdonck DL; Tanner AC; Tolling ST; Michener SL
    Vet Rec; 1994 Jan; 134(1):5-7. PubMed ID: 8128570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial susceptibility of Haemophilus parasuis and Histophilus somni from pigs and cattle in Denmark.
    Aarestrup FM; Seyfarth AM; Angen Ø
    Vet Microbiol; 2004 Jun; 101(2):143-6. PubMed ID: 15172697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.